Is BLES or MRK a better dividend investment in 2026?

BLES currently yields 1.93% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: MRK offers higher current income.

What is the dividend yield difference between BLES and MRK?

BLES has a forward dividend yield of 1.93% ($0.86/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 1.32 percentage points.

Home › Compare › BLES vs MRK

BLES vs MRK: Dividend Comparison 2026

BLES yields 1.93% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MRK wins by $8.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

BLES

● Live price

1.93%

Share price

$44.27

Annual div

$0.86

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.5K

Annual income

$218.89

Full BLES calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — BLES vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BLES	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BLES + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BLES pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLES

Annual income on $10K today (after 15% tax)

$164.20/yr

After 10yr DRIP, annual income (after tax)

$186.06/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, MRK beats the other by $621.69/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLES + MRK for your $10,000?

BLES: 50%MRK: 50%

100% MRK50/50100% BLES

Portfolio after 10yr

$26.6K

Annual income

$584.60/yr

Blended yield

2.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BLES

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLES buys

MRK buys

Politician	Chamber	Ticker	Type	Amount	Date
Josh Gottheimer	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2026-02-04
Michael McCaul	🏢 House	$MRK	▼ Sell	$15,001 - $50,000	2026-01-13
Gilbert Cisneros	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-12-19
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-12-18
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-11-13
Ro Khanna	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-09-29
Val Hoyle	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-09-23
Marjorie Taylor Greene	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-08-28
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-08-14
Gilbert Cisneros	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-08-05

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBLESMRK

Forward yield	1.93%	3.25% ✓
Annual dividend / share	$0.86	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$22.5K	$30.7K ✓
Annual income after 10y	$218.89	$950.29 ✓
Total dividends collected	$2.1K	$6.1K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BLES vs MRK ($10,000, DRIP)

Year	BLES Portfolio	BLES Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$10,893	$193.18	$11,192	$351.54	$299.00 → MRK
2	$11,852	$196.67	$12,524	$392.70	$672.00 → MRK
3	$12,882	$199.99	$14,015	$438.65	$1.1K → MRK
4	$13,987	$203.14	$15,682	$489.96	$1.7K → MRK
5	$15,172	$206.13	$17,547	$547.23	$2.4K → MRK
6	$16,443	$208.97	$19,632	$611.16	$3.2K → MRK
7	$17,806	$211.66	$21,963	$682.53	$4.2K → MRK
8	$19,266	$214.21	$24,571	$762.18	$5.3K → MRK
9	$20,832	$216.62	$27,486	$851.08	$6.7K → MRK
10	$22,509	$218.89	$30,745	$950.29	$8.2K → MRK

BLES vs MRK: Complete Analysis 2026

BLES — Stock

Inspire Global Hope ETF invests into inspiring, biblically aligned large companies from both the U.S. and around the world as determined by Inspire Impact Scores greater than or equal to zero.

Full BLES Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this BLES vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLES vs SCHD BLES vs JEPI BLES vs O BLES vs KO BLES vs MAIN BLES vs JNJ BLES vs ABBV BLES vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.